Getinge AB (GETIb.ST)
26 May 2017
* Says can't rule out further costs related to FDA probe (Adds detail, background, share price)
STOCKHOLM, April 25 Swedish medical technology firm Getinge reported on Tuesday a first-quarter core profit above expectations and repeated guidance for a slightly positive organic sales growth for the full year, sending its shares higher.
* Getinge says Reinhard Mayer, chief financial officer of Getinge, has decided to leave company for family reasons
Jan 26 Medical technology firm Getinge posted a fourth-quarter core profit below market forecasts on Thursday and said it was still awaiting reply from the U.S. Food and Drug Administration (FDA) on work to improve quality controls at one of its plants.
* Getinge q4 order intake increased by 3.1% to sek 8,582 m (8,326). Order intake declined organically by 1.1%.